Cymabay Therapeutics (CBAY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2013 | 12-2012 | 12-2006 | |
| Sales | 0 | 3,050 | 0 |
| Gross Profit | N/A | 3,050 | N/A |
| Operating Expenses | 9,396 | 13,488 | 0 |
| Operating Income | -9,396 | -10,438 | N/A |
| Interest Expense | 822 | 841 | 0 |
| Other Income | 145 | 24 | 0 |
| Pre-tax Income | -10,073 | -11,255 | 0 |
| Net Income Continuous | -10,073 | -11,255 | N/A |
| Net Income | $-10,073 | $-11,255 | $N/A |
| EPS Basic Total Ops | 103.52 | -4,128.71 | N/A |
| EPS Basic Continuous Ops | -4.27 | -1,944.54 | N/A |
| EPS Diluted Total Ops | -3.54 | -4,128.71 | N/A |
| EPS Diluted Continuous Ops | -3.54 | -1,944.54 | N/A |
| EBITDA(a) | $-9,283 | $-10,319 | $N/A |